Alopecia following treatment with dextran sulphate and other anticoagulant drugs.
作者信息
TUDHOPE G R, COHEN H, MEIKLE R W
出版信息
Br Med J. 1958 May 3;1(5078):1034-7. doi: 10.1136/bmj.1.5078.1034.
Abstract
摘要
相似文献
1
Alopecia following treatment with dextran sulphate and other anticoagulant drugs.
Br Med J. 1958 May 3;1(5078):1034-7. doi: 10.1136/bmj.1.5078.1034.
2
[Thromboelastographic studies of the anticoagulant action in vivo of dextran sulfate].
Prog Med (Napoli). 1958 Mar 31;14(6):167-71.
3
The use of dextran sulfate as an anticoagulant for open-heart surgery.
Surg Forum. 1958;9:143-5.
4
The anticoagulant activity of dextran sulphate. II. The effect of dextran sulphate on the one-stage prothrombin time.
J Pharm Pharmacol. 1956 Aug;8(8):589-601. doi: 10.1111/j.2042-7158.1956.tb12190.x.
5
The use of dextran sulphate as a blood anticoagulant in biological research.
J Clin Pathol. 1952 Nov;5(4):366. doi: 10.1136/jcp.5.4.366.
6
7
The anticoagulant activity and toxicity of dextran sulphate and a xylan polysulphuric acid.
Scand J Clin Lab Invest. 1955;7(3):204-11. doi: 10.3109/00365515509134511.
8
Experiments with dextran sulphate as an anticoagulant.
Proc R Soc Med. 1951 Jul;44(7):563-4. doi: 10.1177/003591575104400710.
9
Dextran sulphate: use as an anticoagulant, and action in lowering serum cholesterol.
Br Med J. 1956 Nov 3;2(5000):1023-7. doi: 10.1136/bmj.2.5000.1023.
10
Chronic toxicity of dextran sulphate in rabbits.
Br J Pharmacol Chemother. 1958 Jun;13(2):109-12. doi: 10.1111/j.1476-5381.1958.tb00203.x.
引用本文的文献
1
Direct-acting oral anticoagulants and alopecia: The valuable support of postmarketing data.
Br J Clin Pharmacol. 2020 Aug;86(8):1654-1660. doi: 10.1111/bcp.14221. Epub 2020 Feb 18.
2
Agent specific effects of anticoagulant induced alopecia.
Res Pract Thromb Haemost. 2017 Jul;1(1):90-92. doi: 10.1002/rth2.12001. Epub 2017 May 30.
3
Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature.
Drugs Real World Outcomes. 2016 Mar;3(1):1-6. doi: 10.1007/s40801-015-0056-z.
4
Madarosis: a marker of many maladies.
Int J Trichology. 2012 Jan;4(1):3-18. doi: 10.4103/0974-7753.96079.
5
[On changes of skin connective tissue during the hair growth cycle in the mouse].
Arch Klin Exp Dermatol. 1959;209:426-34.
6
Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection.
Antimicrob Agents Chemother. 1991 Dec;35(12):2544-50. doi: 10.1128/AAC.35.12.2544.
本文引用的文献
1
Hyperheparinemia: Cause of the Hemorrhagic Syndrome Associated With Total Body Exposure to Ionizing Radiation.
Science. 1947 Apr 11;105(2728):388-9. doi: 10.1126/science.105.2728.388.
2
Epilation in the non-irradiated member of parabiotically united rats.
Proc Soc Exp Biol Med. 1949 Oct;72(1):266-9. doi: 10.3181/00379727-72-17402.
3
Dextran sulphate--a synthetic analogue of heparin.
Biochem J. 1952 Apr;51(1):129-33. doi: 10.1042/bj0510129.
4
The administration of heparin.
Surg Gynecol Obstet. 1951 Sep;93(3):343-62.
5
Dextran sulphate: use as an anticoagulant, and action in lowering serum cholesterol.
Br Med J. 1956 Nov 3;2(5000):1023-7. doi: 10.1136/bmj.2.5000.1023.
6
Duration of anticoagulant effect in relation to urinary excretion of dextran sulphate.
Br Med J. 1956 Nov 3;2(5000):1016-23. doi: 10.1136/bmj.2.5000.1016.
7
A controlled study of the effect of intermittent heparin therapy on the course of human coronary atherosclerosis.
Circulation. 1956 Apr;13(4):489-98. doi: 10.1161/01.cir.13.4.489.
8
The anticoagulant activity and toxicity of dextran sulphate and a xylan polysulphuric acid.
Scand J Clin Lab Invest. 1955;7(3):204-11. doi: 10.3109/00365515509134511.
9
Alopecia and other toxic effects of heparin and synthetic heparinoids.
Am J Med Sci. 1954 Mar;227(3):279-82.
10
Anticoagulant therapy.
Surgery. 1953 Dec;34(6):985-1004.
Zotero 插件